Incentives to Resistence
Frank Pasquale writes at Madisonian.net about how the limited term of pharmaceutical patent leads to increased drug resistence. Pharmaceutical companies’ need to sell a drug before its patent expires means that they may push doctors to use newer drugs when older ones would suffice. As a result, diseases resistant to the new drugs develop more quickly than they otherwise would.